Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | CASP1 | P29466 | 1/20 | 1.00 |
| ▸ | MPI | P34949 | 1/20 | 1.00 |
| ▸ | CACNA1B | Q00975 | 1/20 | 1.00 |
| ▸ | APBA1 | Q02410 | 1/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | APAF1 | O14727 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | UBE2N | P61088 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29437299 | 1.00 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2HPGDCASP1MPI | |
| SCHEMBL117049 | 0.87 | CYP1B1 (1.00) | ALDH1A1SMN1; SMN2HPGDCASP1MPI | |
| SCHEMBL7131251 | 0.83 | ALDH1A1 (0.71) | ALDH1A1SMN1; SMN2HPGDCASP1MPI | |
| SCHEMBL9720971 | 0.82 | HPGD (0.70) | ALDH1A1SMN1; SMN2HPGDCASP1MPI | |
| SCHEMBL7130039 | 0.81 | HPGD (0.69) | ALDH1A1SMN1; SMN2HPGDCASP1MPI | |
| SCHEMBL9720875 | 0.81 | ALDH1A1 (0.68) | ALDH1A1SMN1; SMN2HPGDCASP1MPI | |
| SCHEMBL9720969 | 0.80 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2HPGDCASP1MPI | |
| SCHEMBL11211234 | 0.80 | HPGD (0.66) | ALDH1A1SMN1; SMN2HPGDCASP1MPI | |
| SCHEMBL7071975 | 0.79 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2HPGDCASP1MPI | |
| SCHEMBL9290383 | 0.79 | HEXA (0.78) | ALDH1A1SMN1; SMN2HPGDCASP1MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159762-A1 | NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION | REVVITY HEALTH SCIENCES, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230159762-A1 | NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION | REVVITY HEALTH SCIENCES, INC. | 2023-05-25 | — | — | US | disclosed |
| US-11549017-B2 | NIR to SWIR fluorescent compounds for imaging and detection | PERKINELMER HEALTH SCIENCES, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| CN-111662226-B | 2-oxo-1, 2-dihydrobenzo [ cd ] indole compound | 中国科学院广州生物医药与健康研究院 | 2022-03-18 | — | — | CN | disclosed |
| US-20210130581-A1 | NEAR INFRARED (NIR) LASER PROCESSING OF RESIN BASED ARTICLES | AGFA-GEVAERT NV (BE) | 2021-05-06 | — | — | US | disclosed |
| US-20210016588-A1 | NEAR INFRARED (NIR) LASER PROCESSING | AGFA-GEVAERT NV (BE) | 2021-01-21 | — | — | US | disclosed |
| CN-105985282-B | 2-oxo-1, 2-dihydrobenzo [ cd ] indole compound and application thereof | 中国科学院广州生物医药与健康研究院 | 2020-12-08 | — | — | CN | disclosed |
| CN-111662226-A | 2-oxo-1, 2-dihydrobenzo [ cd ] indole compound | 中国科学院广州生物医药与健康研究院 | 2020-09-15 | — | — | CN | disclosed |
| US-20200148907-A1 | NEAR INFRARED (NIR) LASER MARKABLE COMPOSITIONS | AGFA NV (BE) | 2020-05-14 | — | — | US | disclosed |
| WO-2019110438-A1 | NEAR INFRARED (NIR) LASER PROCESSING | AGFA NV (BE) | 2019-06-13 | — | — | WO | disclosed |
| EP-0050263-B1 | CATIONIC DYES, THEIR PREPARATION AND THEIR USE IN THE DYEING OF CATIONICALLY DYEABLE FIBRES AND PAPER | BAYER AG (DE) | 1983-08-03 | — | — | EP | disclosed |
| EP-0081125-A1 | Cationic dyes, their preparation process and their use in dyeing and mass dyeing | BAYER AG (DE) | 1983-06-15 | — | — | EP | disclosed |
| US-4332937-A | DYES FOR POLYACRYLONITRILE | CIBA-GEIGY CORPORATION (US) | 1982-06-01 | — | — | US | disclosed |
| EP-0050263-A1 | Cationic dyes, their preparation and their use in the dyeing of cationically dyeable fibres and paper | BAYER AG (DE) | 1982-04-28 | — | — | EP | disclosed |
| US-4283540-A | ETHERIFICATION OF A CATIONIC DYE WITH A POLYHYDRIC ALCOHOL | BAYER AKTIENGESELLSCHAFT (DE) | 1981-08-11 | — | — | US | disclosed |
| US-4185151-A | 1-R-2-(U-HYDROXYALKYL-2,2,4-TRIMETHYL TETRAHYDROQUINOL-6-YL) BENZ(CD)INDOLES | BAYER AKTIENGESELLSCHAFT (DE) | 1980-01-22 | — | — | US | disclosed |
| US-RE29834-E | PREPARED FROM 4-SULFONYL-1,8-NAPHTHOLACTAMS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-11-14 | — | — | US | disclosed |
| US-4080331-A | 2-DICYANOMETHYLENE BENZINDOLE DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1978-03-21 | — | — | US | disclosed |
| US-3971807-A | BENZINDOLE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | disclosed |
| US-3959310-A | BENZINDOLE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11549017-B2 | NIR to SWIR fluorescent compounds for imaging and detection | SMARCD1, SMARCE1, SMARCB1 | ALDH1A1 3287/4885SMN1; SMN2 1516/4885HPGD 2747/4885 |
| US-20230159762-A1 | NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION | SMARCD1, SMARCE1, SMARCB1 | ALDH1A1 3287/4885SMN1; SMN2 1516/4885HPGD 2747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.